戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ens (2 with Ehrlichia chaffeensis and 1 with Mycoplasma pneumoniae).
2 oplasma genitalium and its closest relative, Mycoplasma pneumoniae.
3 ted B/C proteins (P90/P40), respectively, in Mycoplasma pneumoniae.
4 al organelle of the cell wall-less bacterium Mycoplasma pneumoniae.
5  of these differences by analysing RuvA from Mycoplasma pneumoniae.
6  rat and human SP-D with the human pathogen, Mycoplasma pneumoniae.
7 m 8% for Methanococcus jannaschii to 37% for Mycoplasma pneumoniae.
8 tococcus pneumoniae, Legionella species, and Mycoplasma pneumoniae.
9 dynamics of translation inside the bacterium Mycoplasma pneumoniae.
10 um tuberculosis, Neisseria meningitidis, and Mycoplasma pneumoniae.
11 s-reacting antibodies to the closely related Mycoplasma pneumoniae.
12 lated ubiquitous respiratory tract pathogen, Mycoplasma pneumoniae.
13 philus influenzae, Chlamydia pneumoniae, and Mycoplasma pneumoniae.
14 ld-type copies, including the ruvA gene from Mycoplasma pneumoniae.
15 is (MLVA) method for the molecular typing of Mycoplasma pneumoniae.
16 8; coronavirus, 7; parainfluenza virus 4, 4; Mycoplasma pneumoniae, 1).
17 uenza, 6% herpes simplex virus (HSV), and 6% Mycoplasma pneumoniae; 25% (95% CI, 20%-30%) had immune-
18  genitalium (26.3%) and the P1 cytadhesin of Mycoplasma pneumoniae (28.7%).
19 micdadei, 9 and 80 CFU/ml, respectively; for Mycoplasma pneumoniae, 5 CFU/ml; and for Chlamydia (Chla
20                     The wall-less prokaryote Mycoplasma pneumoniae, a common cause of chronic respira
21 e increased inflammatory response induced by Mycoplasma pneumoniae, a pathogen known to exacerbate as
22 ccus pneumoniae, Haemophilus influenzae, and Mycoplasma pneumoniae accounting for most identified bac
23                                              Mycoplasma pneumoniae accounts for 20 to 30% of all comm
24                                              Mycoplasma pneumoniae adherence to host cells is a multi
25                                              Mycoplasma pneumoniae adsorbs to host respiratory epithe
26                                              Mycoplasma pneumoniae, an atypical human pathogen, has b
27 ypical bacteria Chlamydophila pneumoniae and Mycoplasma pneumoniae and asthma pathogenesis; however,
28  urine pneumococcal and legionella antigens, Mycoplasma pneumoniae and Chlamydia pneumoniae antibodie
29       We assessed the utility of culture for Mycoplasma pneumoniae and Chlamydophila pneumoniae to di
30                                       Airway Mycoplasma pneumoniae and human rhinovirus (HRV) infecti
31  these processes in the pathogenic bacterium Mycoplasma pneumoniae and its close relatives have also
32 .8% and 16.7%, and Streptococcus pneumoniae, Mycoplasma pneumoniae and Klebsiella pneumoniae are the
33  genes encoding the P30 adhesin (one UGA) of Mycoplasma pneumoniae and methionine sulfoxide reductase
34                      Mice were infected with Mycoplasma pneumoniae and monitored for the synthesis an
35 ifferent mycoplasmas of clinical importance (Mycoplasma pneumoniae and Mycoplasma fermentans) were ex
36                                              Mycoplasma pneumoniae and Mycoplasma genitalium are clos
37 es with cytadhesin-related functions in both Mycoplasma pneumoniae and Mycoplasma genitalium.
38 mnose was detected in the d configuration in Mycoplasma pneumoniae and Mycoplasma pulmonis, and in bo
39 llin-resistant Staphylococcus aureus (MRSA), Mycoplasma pneumoniae , and Candida albicans .
40 sciscella tularensis, Ehrlichia chaffeensis, Mycoplasma pneumoniae, and Escherichia coli, although ot
41 s, and marginally in Haemophilus influenzae, Mycoplasma pneumoniae, and Helicobacter pylori.
42 sthma inception, while Chlamydia pneumoniae, Mycoplasma pneumoniae, and latent adenovirus infections
43 the cytadherence-associated protein P65 from Mycoplasma pneumoniae, and MGA_0928, the M. gallisepticu
44 species representing the Mycoplasma hominis, Mycoplasma pneumoniae, and Spiroplasma phylogenetic clus
45                The cell wall-less prokaryote Mycoplasma pneumoniae approaches the minimal requirement
46                  Atypical pathogens (notably mycoplasma pneumoniae) are now known to cause a wide spe
47 n technology, was used to initially identify Mycoplasma pneumoniae as the causative agent in this out
48                                              Mycoplasma pneumoniae ASCs measured by enzyme-linked imm
49                                              Mycoplasma pneumoniae ASCs of the isotype IgM were found
50                                              Mycoplasma pneumoniae ASCs were detected from 2 days to
51                                              Mycoplasma pneumoniae ASCs were undetectable in HCs, in
52                                              Mycoplasma pneumoniae attachment to host cells requires
53 he smallest and simplest of all known cells, Mycoplasma pneumoniae builds a surprisingly large and co
54                            Pathogens such as Mycoplasma pneumoniae can exacerbate airway inflammation
55                                              Mycoplasma pneumoniae causes acute and chronic respirato
56                                              Mycoplasma pneumoniae causes atypical pneumonia in child
57                The cell wall-less prokaryote Mycoplasma pneumoniae causes bronchitis and atypical pne
58                The cell wall-less prokaryote Mycoplasma pneumoniae causes tracheobronchitis and prima
59 ntify ribosomes in images of frozen-hydrated Mycoplasma pneumoniae cells with high precision and sens
60 cryo-microscopy (cryo-EM) images of untilted Mycoplasma pneumoniae cells with high precision.
61 espiratory syncytial virus A (RSV A), RSV B, Mycoplasma pneumoniae, Chlamydophila pneumoniae, Legione
62  as Bordetella pertussis pertussis toxin and Mycoplasma pneumoniae community-acquired respiratory dis
63                                              Mycoplasma pneumoniae continues to be a significant caus
64                                              Mycoplasma pneumoniae cytadherence is mediated by a spec
65  in gene MPN142 (orf6) was identified in the Mycoplasma pneumoniae cytadherence mutant III-4.
66          A new genetic locus associated with Mycoplasma pneumoniae cytadherence was previously identi
67  surface protein P65 is a constituent of the Mycoplasma pneumoniae cytoskeleton and is present at red
68 ays derived from distinct genomic regions of Mycoplasma pneumoniae during an outbreak.
69 e (82%) predictive values when compared with Mycoplasma pneumoniae enzyme-linked immunosorbent assay.
70                      The genomic sequence of Mycoplasma pneumoniae establish this cell-wall-less prok
71                                              Mycoplasma pneumoniae exhibits a novel form of gliding m
72 e most closely related to the members of the Mycoplasma pneumoniae group.
73                               Infection with Mycoplasma pneumoniae has been shown to exacerbate asthm
74                                              Mycoplasma pneumoniae has been shown to induce airway in
75                                              Mycoplasma pneumoniae has no cell wall but possesses a c
76 mucosal pathogens, Mycoplasma genitalium and Mycoplasma pneumoniae, has helped define the essential f
77                     Family 2 lipoproteins of Mycoplasma pneumoniae have a conserved "mycoplasma lipop
78 tes known, and yet several species including Mycoplasma pneumoniae have a remarkably complex cellular
79  preceding respiratory tract infections with Mycoplasma pneumoniae have been reported in some cases,
80  clinically concomitant with either positive Mycoplasma pneumoniae IgM or PCR testing from January 1,
81 rom patients involved in a large outbreak of Mycoplasma pneumoniae in a closed religious community in
82 -bp element present within the chromosome of Mycoplasma pneumoniae in at least 10 copies.
83 ectrum of neurologic disease attributable to Mycoplasma pneumoniae in children is incompletely unders
84 to regulate various immune responses to live Mycoplasma pneumoniae in SP-A knockout mice and RAW 264.
85                                   Studies on Mycoplasma pneumoniae in Thailand have focused on urban
86 that SP-A binds to and is bacteriostatic for Mycoplasma pneumoniae in vitro.
87 incidence of atypical bacteria LRIs (notably Mycoplasma pneumoniae) in children is now recognized.
88 ed the effects of different timing of airway Mycoplasma pneumoniae infection on bronchial hyperrespon
89 onic eosinophilic pneumonia complicated with Mycoplasma pneumoniae infection was diagnosed on the bas
90     To investigate the pathogenesis of acute Mycoplasma pneumoniae infection, BALB/c mice were anesth
91 principal laboratory method used to diagnose Mycoplasma pneumoniae infection.
92                                              Mycoplasma pneumoniae infections represent a major prima
93 ting human herpes virus (HHV1-HHV7), HEV, or Mycoplasma pneumoniae infections using throat swab virus
94 lung inflammatory responses to bacteria (eg, Mycoplasma pneumoniae) involved in lung disease exacerba
95 iratory distress syndrome (CARDS) toxin from Mycoplasma pneumoniae is a 591-amino-acid virulence fact
96                                              Mycoplasma pneumoniae is a bacterial pathogen of the hum
97                                              Mycoplasma pneumoniae is a cell wall-less bacterial path
98 e of the cell wall-less pathogenic bacterium Mycoplasma pneumoniae is a complex structure involved in
99                                              Mycoplasma pneumoniae is a human pathogen causing respir
100                                              Mycoplasma pneumoniae is a human pathogen that resides i
101                                              Mycoplasma pneumoniae is a leading cause of community-ac
102                                              Mycoplasma pneumoniae is a leading cause of community-ac
103                                              Mycoplasma pneumoniae is a leading cause of pneumonia an
104                                              Mycoplasma pneumoniae is a leading cause of respiratory
105                                              Mycoplasma pneumoniae is a major cause of bronchitis and
106                                              Mycoplasma pneumoniae is a major cause of community-acqu
107                The cell wall-less prokaryote Mycoplasma pneumoniae is a major cause of community-acqu
108                                              Mycoplasma pneumoniae is a major cause of tracheobronchi
109                                              Mycoplasma pneumoniae is a major human respiratory patho
110                                              Mycoplasma pneumoniae is a minimal microbe with respect
111                  The attachment organelle of Mycoplasma pneumoniae is a polar, tapered cell extension
112                                              Mycoplasma pneumoniae is a significant cause of pneumoni
113                                              Mycoplasma pneumoniae is a significant human respiratory
114                                              Mycoplasma pneumoniae is a small bacterium without a cel
115                                              Mycoplasma pneumoniae is a wall-less human respiratory t
116                                              Mycoplasma pneumoniae is an atypical bacterial respirato
117                                              Mycoplasma pneumoniae is an extracellular pathogen that
118                                              Mycoplasma pneumoniae is an important cause of respirato
119                          Macrolide-resistant Mycoplasma pneumoniae is an increasing problem worldwide
120                                      Because Mycoplasma pneumoniae is hypothesized to play an importa
121 nducting airways of humans by the prokaryote Mycoplasma pneumoniae is mediated by a differentiated te
122             Unlike many bacterial pathogens, Mycoplasma pneumoniae is not known to produce classical
123                                              Mycoplasma pneumoniae is the leading cause of bacterial
124                                              Mycoplasma pneumoniae is the leading cause of bacterial
125                                              Mycoplasma pneumoniae is the leading cause of pneumonia
126                                              Mycoplasma pneumoniae, long appreciated as one of the tr
127                The cell-wall-less prokaryote Mycoplasma pneumoniae, long considered among the smalles
128 s-sectional study aimed to determine whether Mycoplasma pneumoniae (M. pneumoniae) IgG positivity is
129 licobacter pylori, Methanococcus jannaschii, Mycoplasma pneumoniae, M. genitalium, and Synechocystis
130 t S. pneumoniae, or Chlamydia pneumoniae and Mycoplasma pneumoniae may facilitate the clinical manage
131                    The terminal organelle of Mycoplasma pneumoniae mediates cytadherence and gliding
132                                            A Mycoplasma pneumoniae mouse model and a fluorescent cell
133                          The epidemiology of Mycoplasma pneumoniae (Mp) among US children (<18 years)
134                                              Mycoplasma pneumoniae (Mp) cytadherence requires the pro
135                                              Mycoplasma pneumoniae (Mp) frequently colonizes the airw
136                                 Outbreaks of Mycoplasma pneumoniae (MP) in closed communities can hav
137 eliable signs or symptoms that differentiate Mycoplasma pneumoniae (Mp) infection in community-acquir
138                                              Mycoplasma pneumoniae (Mp) infections cause tracheobronc
139                                        While Mycoplasma pneumoniae (MP) infections typically present
140 own high accuracies, but are understudied in Mycoplasma pneumoniae (Mp) infections.
141                                              Mycoplasma pneumoniae (MP) is considered a common cause
142                                In total, 265 Mycoplasma pneumoniae (MP) patients were included, with
143 d recognition and degradation of an extended Mycoplasma pneumoniae (MP) tmRNA tag by the MP-Lon prote
144            Respiratory infections, including Mycoplasma pneumoniae (Mp), contribute to asthma pathobi
145 atory infections, such as atypical bacterium Mycoplasma pneumoniae (Mp), have been proposed to worsen
146          SP-A has a bacteriostatic effect on Mycoplasma pneumoniae (Mp), which occurs by binding surf
147 ecently demonstrated that the measurement of Mycoplasma pneumoniae (Mp)-specific immunoglobulin (Ig)M
148 UNC1 in vitro antibacterial property against Mycoplasma pneumoniae (Mp).
149 athogens Staphylococcus aureus (SaEf-Tu) and Mycoplasma pneumoniae (MpnEf-Tu), and the porcine pathog
150 indicate the extent that macrolide-resistant Mycoplasma pneumoniae (MRMp) occurs in the United States
151 ma pneumoniae (MSMP) and Macrolide-Resistant Mycoplasma pneumoniae (MRMP).
152 n children infected with Macrolide-Sensitive Mycoplasma pneumoniae (MSMP) and Macrolide-Resistant Myc
153 neous, hemadsorption-negative (HA-) class II Mycoplasma pneumoniae mutants that displayed P30 adhesin
154 mophilus influenzae, Neisseria meningitidis, Mycoplasma pneumoniae, Mycobacterium tuberculosis, and B
155 l of antimicrobial susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasm
156 ted six commercial molecular tests targeting Mycoplasma pneumoniae, namely, the BioFire FilmArray res
157                A nested PCR specific for the Mycoplasma pneumoniae P1 gene was used to diagnose mycop
158 ned the structure of full length HPrK/P from Mycoplasma pneumoniae (PD8 ID, 1KNX) to 2.5A resolution.
159             Early distinction between severe Mycoplasma pneumoniae pneumonia (MPP) and mild MPP is st
160  be involved in the pathogenesis of children Mycoplasma pneumoniae pneumonia (MPP).
161 ma pneumoniae pneumonia (RMPP) from ordinary Mycoplasma pneumoniae pneumonia (OMPP).
162 arkers for rapidly distinguishing refractory Mycoplasma pneumoniae pneumonia (RMPP) from ordinary Myc
163 steroids appears to be beneficial for severe Mycoplasma pneumoniae pneumonia in children, but data in
164 no recommended epidemic-control measures for Mycoplasma pneumoniae pneumonia outbreaks in closed comm
165                                              Mycoplasma pneumoniae protein P200 was localized to the
166                                              Mycoplasma pneumoniae proteins HMW1-HMW3 collectively ar
167 t of detection was </=88 CFU/reaction for 10 Mycoplasma pneumoniae reference strains.
168                              Because chronic Mycoplasma pneumoniae respiratory infection is hypothesi
169 r a prolonged period of low detection rates, Mycoplasma pneumoniae resurged in China, during Septembe
170                  Complete genome analysis of Mycoplasma pneumoniae revealed the presence of numerous
171 recovering the known translational states in Mycoplasma pneumoniae ribosomes in situ.
172 the bacterial species Mycoplasma genitalium, Mycoplasma pneumoniae, Shewanella putrefaciens, Synechoc
173                                              Mycoplasma pneumoniae should be included in the differen
174                                              Mycoplasma pneumoniae-specific ASCs are short-lived and
175 cell cultures infected with a PyNP-deficient Mycoplasma pneumoniae strain.
176 emophilus influenzae, Mycoplasma genitalium, Mycoplasma pneumoniae, Synechocystis sp. strain PCC6803,
177 ediatric patient secondary to infection with Mycoplasma pneumoniae that progressed to cardiac tampona
178 lla pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae This multicenter evaluation provid
179                      Laboratory tests showed Mycoplasma pneumoniae to be the etiological agent.
180 teins required for adherence of the pathogen Mycoplasma pneumoniae to host respiratory epithelial cel
181  six bacteria that have varied genome sizes (Mycoplasma pneumoniae, Treponema pallidum, Helicobacter
182  The presence of Chlamydophila pneumoniae or Mycoplasma pneumoniae was ascertained by serologic analy
183                                              Mycoplasma pneumoniae was detected in 1.9% of patients a
184 trongly conserved mycoplasmal 16S RNA genes, Mycoplasma pneumoniae was found in the synovial fluid of
185                                              Mycoplasma pneumoniae was more common among children 5 y
186 oach using the genome-reduced human pathogen Mycoplasma pneumoniae We combined whole-cell cross-linki
187                     Chlamydia pneumoniae and Mycoplasma pneumoniae were evaluated as agents of persis
188                                              Mycoplasma pneumoniae, which causes primary atypical pne
189 herichia coli, Streptococcus pneumoniae, and Mycoplasma pneumoniae, which exemplify gram-negative, gr
190 ficant sequence homology to the ORF6 gene of Mycoplasma pneumoniae, which has been shown to play an a
191  identified two surface proteins of virulent Mycoplasma pneumoniae with molecular masses of 45 and 30
192 ly become available for Escherichia coli and Mycoplasma pneumoniae, yielding 443 and 116 heteromultim

 
Page Top